Annual D&A
$6000.00
-$14.00 K-70.00%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual depreciation & amortization is $6000.00, with the most recent change of -$14.00 thousand (-70.00%) on December 31, 2023.
- During the last 3 years, NRBO annual D&A has fallen by -$40.00 thousand (-86.96%).
- NRBO annual D&A is now -87.50% below its all-time high of $48.00 thousand, reached on December 31, 2021.
Performance
NRBO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$5000.00
-$1000.00-16.67%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly depreciation & amortization is $5000.00, with the most recent change of -$1000.00 (-16.67%) on September 30, 2024.
- Over the past year, NRBO quarterly D&A has increased by +$1000.00 (+25.00%).
- NRBO quarterly D&A is now -58.33% below its all-time high of $12.00 thousand, reached on December 31, 2019.
Performance
NRBO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$19.00 K
+$4000.00+26.67%
September 30, 2024
Summary
- As of February 12, 2025, NRBO TTM depreciation & amortization is $19.00 thousand, with the most recent change of +$4000.00 (+26.67%) on September 30, 2024.
- Over the past year, NRBO TTM D&A has increased by +$13.00 thousand (+216.67%).
- NRBO TTM D&A is now -60.42% below its all-time high of $48.00 thousand, reached on September 30, 2021.
Performance
NRBO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
NRBO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -70.0% | +25.0% | +216.7% |
| 3 y3 years | -87.0% | -58.3% | -60.4% |
| 5 y5 years | +100.0% | +25.0% | +11.8% |
NRBO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.5% | at low | -58.3% | -100.0% | -60.4% | +533.3% |
| 5 y | 5-year | -87.5% | at low | -58.3% | -100.0% | -60.4% | +533.3% |
| alltime | all time | -87.5% | -100.0% | -58.3% | -100.0% | -60.4% | -100.0% |
NeuroBo Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5000.00(-16.7%) | $19.00 K(+26.7%) |
| Jun 2024 | - | $6000.00(+50.0%) | $15.00 K(+66.7%) |
| Mar 2024 | - | $4000.00(0.0%) | $9000.00(+50.0%) |
| Dec 2023 | $6000.00(-70.0%) | $4000.00(+300.0%) | $6000.00(+100.0%) |
| Sep 2023 | - | $1000.00(>+9900.0%) | $3000.00(-25.0%) |
| Jun 2023 | - | $0.00(-100.0%) | $4000.00(-55.6%) |
| Mar 2023 | - | $1000.00(0.0%) | $9000.00(-55.0%) |
| Dec 2022 | $20.00 K(-58.3%) | $1000.00(-50.0%) | $20.00 K(-35.5%) |
| Sep 2022 | - | $2000.00(-60.0%) | $31.00 K(-24.4%) |
| Jun 2022 | - | $5000.00(-58.3%) | $41.00 K(-14.6%) |
| Mar 2022 | - | $12.00 K(0.0%) | $48.00 K(0.0%) |
| Dec 2021 | $48.00 K | $12.00 K(0.0%) | $48.00 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $12.00 K(0.0%) | $48.00 K(+2.1%) |
| Jun 2021 | - | $12.00 K(0.0%) | $47.00 K(0.0%) |
| Mar 2021 | - | $12.00 K(0.0%) | $47.00 K(+2.2%) |
| Dec 2020 | $46.00 K(+170.6%) | $12.00 K(+9.1%) | $46.00 K(0.0%) |
| Sep 2020 | - | $11.00 K(-8.3%) | $46.00 K(+17.9%) |
| Jun 2020 | - | $12.00 K(+9.1%) | $39.00 K(+39.3%) |
| Mar 2020 | - | $11.00 K(-8.3%) | $28.00 K(+64.7%) |
| Dec 2019 | $17.00 K(>+9900.0%) | $12.00 K(+200.0%) | $17.00 K(+240.0%) |
| Sep 2019 | - | $4000.00(+300.0%) | $5000.00(+400.0%) |
| Jun 2019 | - | $1000.00(>+9900.0%) | $1000.00(>+9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $0.00 | - | - |
FAQ
- What is NeuroBo Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual D&A year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly D&A year-on-year change?
- What is NeuroBo Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals TTM D&A year-on-year change?
What is NeuroBo Pharmaceuticals annual depreciation & amortization?
The current annual D&A of NRBO is $6000.00
What is the all time high annual D&A for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual depreciation & amortization is $48.00 K
What is NeuroBo Pharmaceuticals annual D&A year-on-year change?
Over the past year, NRBO annual depreciation & amortization has changed by -$14.00 K (-70.00%)
What is NeuroBo Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of NRBO is $5000.00
What is the all time high quarterly D&A for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly depreciation & amortization is $12.00 K
What is NeuroBo Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, NRBO quarterly depreciation & amortization has changed by +$1000.00 (+25.00%)
What is NeuroBo Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of NRBO is $19.00 K
What is the all time high TTM D&A for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high TTM depreciation & amortization is $48.00 K
What is NeuroBo Pharmaceuticals TTM D&A year-on-year change?
Over the past year, NRBO TTM depreciation & amortization has changed by +$13.00 K (+216.67%)